InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Beaurang Pierre, Directeur Commercial. Officer active across 1 companies, notably Nurix Therapeutics, Inc.. Aggregated, 8 reports have been recorded. The latest transaction was disclosed on 10 August 2021 — Levée d'options. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€7,1017,500 shares@ €0.94680.0004% mcap25.5% of flow
Common Stock
SEC:0001209191-21-050976·
€7,1017,500 shares@ €0.94680.0004% mcap12.8% of flow
Common Stock
SEC:0001209191-21-050976:0·
€7,0167,500 shares@ €0.93550.0004% mcap25.2% of flow
Common Stock
SEC:0001209191-21-046362·
€7,0167,500 shares@ €0.93550.0004% mcap12.6% of flow
Common Stock
SEC:0001209191-21-046362:0·
€6,8397,500 shares@ €0.91190.0004% mcap24.6% of flow
Common Stock
SEC:0001209191-21-039810·
€6,8397,500 shares@ €0.91190.0004% mcap12.3% of flow
Common Stock
SEC:0001209191-21-039810:0·
€6,8577,500 shares@ €0.91430.0004% mcap24.7% of flow
Common Stock
SEC:0001209191-21-031891·
€6,8577,500 shares@ €0.91430.0004% mcap12.3% of flow
Common Stock
SEC:0001209191-21-031891:0·
8 of 8 declarations
About Beaurang Pierre
Pierre Beaurang is the Chief Business Officer at Nurix Therapeutics, Inc. In this role, he is responsible for the business strategy and growth of the company. With a strong background in the biopharmaceutical sector, he plays a key role in expanding operations and innovating products. His leadership is essential to achieving the company's objectives.
